

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.41790762 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 5.41790762 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.41790762 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.41790762 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.41790762 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.41790762 |
| 7 | microglial cell activation (GO:0001774) | 5.17872109 |
| 8 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.65911158 |
| 9 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.35530150 |
| 10 | C4-dicarboxylate transport (GO:0015740) | 4.15682713 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 4.14816412 |
| 12 | auditory behavior (GO:0031223) | 3.94493187 |
| 13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.93553490 |
| 14 | neuron cell-cell adhesion (GO:0007158) | 3.88087848 |
| 15 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.87294598 |
| 16 | response to host immune response (GO:0052572) | 3.87294598 |
| 17 | nucleobase catabolic process (GO:0046113) | 3.79327873 |
| 18 | gamma-aminobutyric acid transport (GO:0015812) | 3.73297333 |
| 19 | mechanosensory behavior (GO:0007638) | 3.72339687 |
| 20 | locomotory exploration behavior (GO:0035641) | 3.68550548 |
| 21 | positive regulation of heat generation (GO:0031652) | 3.68139434 |
| 22 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.48359672 |
| 23 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.42851485 |
| 24 | neuronal action potential propagation (GO:0019227) | 3.42496987 |
| 25 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.41096802 |
| 26 | regulation of synapse structural plasticity (GO:0051823) | 3.40024819 |
| 27 | postsynaptic membrane organization (GO:0001941) | 3.39610983 |
| 28 | response to host (GO:0075136) | 3.33479304 |
| 29 | response to host defenses (GO:0052200) | 3.33479304 |
| 30 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.33479304 |
| 31 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.32745369 |
| 32 | response to auditory stimulus (GO:0010996) | 3.32247112 |
| 33 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.32153437 |
| 34 | amino acid import (GO:0043090) | 3.30648942 |
| 35 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.28497164 |
| 36 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.26598572 |
| 37 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.25712188 |
| 38 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.21867092 |
| 39 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.20071150 |
| 40 | positive regulation of antigen processing and presentation (GO:0002579) | 3.16051337 |
| 41 | axonal fasciculation (GO:0007413) | 3.15014246 |
| 42 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.14523649 |
| 43 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.14058645 |
| 44 | negative regulation of interleukin-17 production (GO:0032700) | 3.13650428 |
| 45 | regulation of fever generation (GO:0031620) | 3.12724465 |
| 46 | retinal cone cell development (GO:0046549) | 3.11670829 |
| 47 | regulation of heat generation (GO:0031650) | 3.08727058 |
| 48 | T-helper 1 type immune response (GO:0042088) | 3.06449609 |
| 49 | macrophage activation (GO:0042116) | 3.05465844 |
| 50 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.05371539 |
| 51 | vocalization behavior (GO:0071625) | 3.03852511 |
| 52 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.03348349 |
| 53 | presynaptic membrane assembly (GO:0097105) | 3.02939448 |
| 54 | behavioral response to ethanol (GO:0048149) | 3.02201564 |
| 55 | L-amino acid import (GO:0043092) | 3.00811921 |
| 56 | dendritic spine morphogenesis (GO:0060997) | 2.99845584 |
| 57 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.97086840 |
| 58 | nonmotile primary cilium assembly (GO:0035058) | 2.92803255 |
| 59 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.92650508 |
| 60 | startle response (GO:0001964) | 2.90162764 |
| 61 | lens fiber cell differentiation (GO:0070306) | 2.89966757 |
| 62 | chondroitin sulfate catabolic process (GO:0030207) | 2.85570167 |
| 63 | synaptic vesicle exocytosis (GO:0016079) | 2.84044039 |
| 64 | exploration behavior (GO:0035640) | 2.81405004 |
| 65 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.79826885 |
| 66 | establishment of protein localization to Golgi (GO:0072600) | 2.78272109 |
| 67 | regulation of neurotransmitter uptake (GO:0051580) | 2.77894478 |
| 68 | neuron recognition (GO:0008038) | 2.77514434 |
| 69 | glycosphingolipid catabolic process (GO:0046479) | 2.76039658 |
| 70 | limb bud formation (GO:0060174) | 2.75650922 |
| 71 | intraciliary transport (GO:0042073) | 2.74613873 |
| 72 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.73837102 |
| 73 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.73093170 |
| 74 | synapse assembly (GO:0007416) | 2.71733591 |
| 75 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.71683046 |
| 76 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.69093038 |
| 77 | retinal ganglion cell axon guidance (GO:0031290) | 2.64434466 |
| 78 | response to peptidoglycan (GO:0032494) | 2.64162371 |
| 79 | negative regulation of neurotransmitter transport (GO:0051589) | 2.64099358 |
| 80 | protein targeting to Golgi (GO:0000042) | 2.63927611 |
| 81 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.63191845 |
| 82 | transmission of nerve impulse (GO:0019226) | 2.62837717 |
| 83 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.62183721 |
| 84 | neurotransmitter uptake (GO:0001504) | 2.61906798 |
| 85 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.61742491 |
| 86 | regulation of respiratory system process (GO:0044065) | 2.61633352 |
| 87 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.60541014 |
| 88 | regulation of interleukin-17 production (GO:0032660) | 2.57519534 |
| 89 | regulation of activation of Janus kinase activity (GO:0010533) | 2.57041000 |
| 90 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.56651335 |
| 91 | behavioral response to nicotine (GO:0035095) | 2.56510517 |
| 92 | neural tube formation (GO:0001841) | 2.56341246 |
| 93 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.55624947 |
| 94 | auditory receptor cell stereocilium organization (GO:0060088) | 2.55438575 |
| 95 | regulation of platelet aggregation (GO:0090330) | 2.55399082 |
| 96 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.55141365 |
| 97 | central nervous system neuron axonogenesis (GO:0021955) | 2.53761626 |
| 98 | cellular ketone body metabolic process (GO:0046950) | 2.53015083 |
| 99 | neuron-neuron synaptic transmission (GO:0007270) | 2.52534787 |
| 100 | protein localization to cilium (GO:0061512) | 2.51468361 |
| 101 | glycosphingolipid biosynthetic process (GO:0006688) | 2.51380546 |
| 102 | positive regulation of interleukin-17 production (GO:0032740) | 2.50701745 |
| 103 | reflex (GO:0060004) | 2.50582422 |
| 104 | righting reflex (GO:0060013) | 2.49909906 |
| 105 | synaptic transmission, glutamatergic (GO:0035249) | 2.49627541 |
| 106 | long-term synaptic potentiation (GO:0060291) | 2.49200220 |
| 107 | regulation of beta-amyloid formation (GO:1902003) | 2.46299176 |
| 108 | response to pheromone (GO:0019236) | 2.44688726 |
| 109 | inner ear receptor stereocilium organization (GO:0060122) | 2.44520716 |
| 110 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.44347163 |
| 111 | cilium morphogenesis (GO:0060271) | 2.44237804 |
| 112 | lens fiber cell development (GO:0070307) | 2.43878628 |
| 113 | regulation of timing of cell differentiation (GO:0048505) | 2.43850263 |
| 114 | establishment of mitochondrion localization (GO:0051654) | 2.43547478 |
| 115 | brain morphogenesis (GO:0048854) | 2.43412575 |
| 116 | positive regulation of interferon-alpha production (GO:0032727) | 2.42535553 |
| 117 | ketone body metabolic process (GO:1902224) | 2.42519570 |
| 118 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.42424432 |
| 119 | retinal rod cell development (GO:0046548) | 2.42404581 |
| 120 | lens development in camera-type eye (GO:0002088) | 2.42077789 |
| 121 | neuronal action potential (GO:0019228) | 2.41545324 |
| 122 | acidic amino acid transport (GO:0015800) | 2.41216888 |
| 123 | epithelial cilium movement (GO:0003351) | 2.40459990 |
| 124 | photoreceptor cell differentiation (GO:0046530) | 2.39943807 |
| 125 | eye photoreceptor cell differentiation (GO:0001754) | 2.39943807 |
| 126 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.39510381 |
| 127 | detection of light stimulus involved in visual perception (GO:0050908) | 2.39510381 |
| 128 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.38833331 |
| 129 | vascular smooth muscle contraction (GO:0014829) | 2.36701794 |
| 130 | myeloid cell activation involved in immune response (GO:0002275) | 2.36675798 |
| 131 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.36662243 |
| 132 | cilium organization (GO:0044782) | 2.36644519 |
| 133 | regulation of memory T cell differentiation (GO:0043380) | 2.36033672 |
| 134 | glycolipid catabolic process (GO:0019377) | 2.35967471 |
| 135 | synapse organization (GO:0050808) | 2.34812232 |
| 136 | regulation of antigen processing and presentation (GO:0002577) | 2.34483409 |
| 137 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.34336994 |
| 138 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.33723597 |
| 139 | response to cholesterol (GO:0070723) | 2.33199465 |
| 140 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.32843795 |
| 141 | glutamate receptor signaling pathway (GO:0007215) | 2.32459056 |
| 142 | cilium assembly (GO:0042384) | 2.32306036 |
| 143 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.31915754 |
| 144 | presynaptic membrane organization (GO:0097090) | 2.31411121 |
| 145 | cerebellar granule cell differentiation (GO:0021707) | 2.31167023 |
| 146 | protein localization to Golgi apparatus (GO:0034067) | 2.30802930 |
| 147 | membrane depolarization during action potential (GO:0086010) | 2.30306545 |
| 148 | positive regulation of synapse assembly (GO:0051965) | 2.30053608 |
| 149 | photoreceptor cell maintenance (GO:0045494) | 2.29913248 |
| 150 | synaptic vesicle maturation (GO:0016188) | 2.29488140 |
| 151 | protein polyglutamylation (GO:0018095) | 2.28551956 |
| 152 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.28527013 |
| 153 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.27925941 |
| 154 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.27799676 |
| 155 | photoreceptor cell development (GO:0042461) | 2.25890535 |
| 156 | glial cell proliferation (GO:0014009) | 2.25240074 |
| 157 | regulation of interferon-alpha production (GO:0032647) | 2.25086810 |
| 158 | cerebral cortex cell migration (GO:0021795) | 2.24670405 |
| 159 | detection of calcium ion (GO:0005513) | 2.24667518 |
| 160 | neuromuscular synaptic transmission (GO:0007274) | 2.24543336 |
| 161 | positive regulation of interleukin-12 production (GO:0032735) | 2.24523440 |
| 162 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.23343454 |
| 163 | regulation of cilium movement (GO:0003352) | 2.23240704 |
| 164 | phagosome maturation (GO:0090382) | 2.22766455 |
| 165 | dendrite morphogenesis (GO:0048813) | 2.22151471 |
| 166 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.22017913 |
| 167 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.21736542 |
| 168 | glutamate secretion (GO:0014047) | 2.21541963 |
| 169 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.20080978 |
| 170 | negative regulation of platelet activation (GO:0010544) | 2.19893268 |
| 171 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.19768764 |
| 172 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.19241543 |
| 173 | ceramide catabolic process (GO:0046514) | 2.18994161 |
| 174 | protein localization to synapse (GO:0035418) | 2.15867582 |
| 175 | negative regulation of astrocyte differentiation (GO:0048712) | 2.14167151 |
| 176 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.12794640 |
| 177 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.09994519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.16953859 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.97626542 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.54561633 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.46892863 |
| 5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.33093281 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.29513582 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.22671974 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.21511733 |
| 9 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.08478117 |
| 10 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.07842370 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.07357859 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.05673027 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.03315834 |
| 14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.99345704 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.98113802 |
| 16 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.88200002 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.86390862 |
| 18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.82874496 |
| 19 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.78350034 |
| 20 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.77881559 |
| 21 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.77794141 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.76106607 |
| 23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.74813838 |
| 24 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.73912309 |
| 25 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.73789558 |
| 26 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.73514729 |
| 27 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.73353744 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.72879811 |
| 29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.71860027 |
| 30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.71860027 |
| 31 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.70772357 |
| 32 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.70373554 |
| 33 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.70329876 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.68804059 |
| 35 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.68741964 |
| 36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.66848208 |
| 37 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.64800647 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.64721960 |
| 39 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.64306498 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.64189639 |
| 41 | EWS_26573619_Chip-Seq_HEK293_Human | 1.63831010 |
| 42 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.63591196 |
| 43 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.58292149 |
| 44 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.57583609 |
| 45 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.55547375 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.54183951 |
| 47 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.53237153 |
| 48 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.52016752 |
| 49 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.51723810 |
| 50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.51485070 |
| 51 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.50411806 |
| 52 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.48093778 |
| 53 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47427621 |
| 54 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.46221377 |
| 55 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.46221377 |
| 56 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.45369905 |
| 57 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.43411616 |
| 58 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.42878690 |
| 59 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.42171816 |
| 60 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.39160419 |
| 61 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37902244 |
| 62 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.37576415 |
| 63 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.37457830 |
| 64 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.36195932 |
| 65 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.36121606 |
| 66 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.34769684 |
| 67 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.33558194 |
| 68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32149993 |
| 69 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31787285 |
| 70 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30642450 |
| 71 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.30030373 |
| 72 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.30030373 |
| 73 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.29735142 |
| 74 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.29266563 |
| 75 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.27197295 |
| 76 | FUS_26573619_Chip-Seq_HEK293_Human | 1.26478357 |
| 77 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26258560 |
| 78 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24818406 |
| 79 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.22709121 |
| 80 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22409760 |
| 81 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22301126 |
| 82 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21243724 |
| 83 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.21208833 |
| 84 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.20678961 |
| 85 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17979629 |
| 86 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.17939966 |
| 87 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.17747518 |
| 88 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.17743998 |
| 89 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.16505913 |
| 90 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.16299895 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15367215 |
| 92 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.15312510 |
| 93 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.15265597 |
| 94 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.14575442 |
| 95 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.13662240 |
| 96 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.13156091 |
| 97 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.12518311 |
| 98 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.11436773 |
| 99 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.11317181 |
| 100 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.11126465 |
| 101 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.10332191 |
| 102 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.09842372 |
| 103 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08405546 |
| 104 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.08020728 |
| 105 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07612390 |
| 106 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07596371 |
| 107 | JUN_21703547_ChIP-Seq_K562_Human | 1.05852221 |
| 108 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05209296 |
| 109 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04794441 |
| 110 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04596004 |
| 111 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03779476 |
| 112 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03714550 |
| 113 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.02330708 |
| 114 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02080517 |
| 115 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01417079 |
| 116 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01221268 |
| 117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00940149 |
| 118 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00940149 |
| 119 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00343824 |
| 120 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.00301978 |
| 121 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00084685 |
| 122 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.99927448 |
| 123 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99885439 |
| 124 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99756620 |
| 125 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98762647 |
| 126 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.98163879 |
| 127 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97179287 |
| 128 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.96964764 |
| 129 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.96474714 |
| 130 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.96341882 |
| 131 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95927991 |
| 132 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.94859478 |
| 133 | VDR_22108803_ChIP-Seq_LS180_Human | 0.94264003 |
| 134 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.94197258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003183_abnormal_peptide_metabolism | 3.85806587 |
| 2 | MP0004858_abnormal_nervous_system | 3.29096016 |
| 3 | MP0002254_reproductive_system_inflammat | 3.03200327 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.02103943 |
| 5 | MP0000569_abnormal_digit_pigmentation | 2.84984771 |
| 6 | MP0002735_abnormal_chemical_nociception | 2.83566829 |
| 7 | MP0005646_abnormal_pituitary_gland | 2.70023904 |
| 8 | MP0005645_abnormal_hypothalamus_physiol | 2.46942558 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.44694552 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.41217531 |
| 11 | MP0002736_abnormal_nociception_after | 2.29535294 |
| 12 | MP0010386_abnormal_urinary_bladder | 2.24139017 |
| 13 | MP0005551_abnormal_eye_electrophysiolog | 2.18331727 |
| 14 | MP0006072_abnormal_retinal_apoptosis | 2.14640680 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.07966874 |
| 16 | MP0005253_abnormal_eye_physiology | 2.06545018 |
| 17 | MP0002063_abnormal_learning/memory/cond | 1.97757743 |
| 18 | MP0003635_abnormal_synaptic_transmissio | 1.97158320 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 1.95210322 |
| 20 | MP0002102_abnormal_ear_morphology | 1.88190318 |
| 21 | MP0002638_abnormal_pupillary_reflex | 1.88108375 |
| 22 | MP0006276_abnormal_autonomic_nervous | 1.86557811 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.85634925 |
| 24 | MP0005171_absent_coat_pigmentation | 1.85009762 |
| 25 | MP0002064_seizures | 1.84586533 |
| 26 | MP0009745_abnormal_behavioral_response | 1.83904774 |
| 27 | MP0005310_abnormal_salivary_gland | 1.78974156 |
| 28 | MP0003011_delayed_dark_adaptation | 1.77651350 |
| 29 | MP0000778_abnormal_nervous_system | 1.75080082 |
| 30 | MP0001529_abnormal_vocalization | 1.69862393 |
| 31 | MP0001486_abnormal_startle_reflex | 1.69590039 |
| 32 | MP0002733_abnormal_thermal_nociception | 1.68034330 |
| 33 | MP0005187_abnormal_penis_morphology | 1.64643156 |
| 34 | MP0004510_myositis | 1.64270406 |
| 35 | MP0003787_abnormal_imprinting | 1.63419443 |
| 36 | MP0004270_analgesia | 1.62954638 |
| 37 | MP0003880_abnormal_central_pattern | 1.62699704 |
| 38 | MP0003690_abnormal_glial_cell | 1.62131582 |
| 39 | MP0004885_abnormal_endolymph | 1.61456715 |
| 40 | MP0003136_yellow_coat_color | 1.61427166 |
| 41 | MP0005248_abnormal_Harderian_gland | 1.57797053 |
| 42 | MP0002277_abnormal_respiratory_mucosa | 1.56577483 |
| 43 | MP0002734_abnormal_mechanical_nocicepti | 1.56432884 |
| 44 | MP0001984_abnormal_olfaction | 1.55652823 |
| 45 | MP0002837_dystrophic_cardiac_calcinosis | 1.53443074 |
| 46 | MP0003122_maternal_imprinting | 1.47947018 |
| 47 | MP0002419_abnormal_innate_immunity | 1.47585069 |
| 48 | MP0000604_amyloidosis | 1.46891834 |
| 49 | MP0003634_abnormal_glial_cell | 1.46281341 |
| 50 | MP0001970_abnormal_pain_threshold | 1.45947097 |
| 51 | MP0004924_abnormal_behavior | 1.45108243 |
| 52 | MP0005386_behavior/neurological_phenoty | 1.45108243 |
| 53 | MP0004215_abnormal_myocardial_fiber | 1.44800775 |
| 54 | MP0002557_abnormal_social/conspecific_i | 1.42634887 |
| 55 | MP0002822_catalepsy | 1.41048970 |
| 56 | MP0004142_abnormal_muscle_tone | 1.40652761 |
| 57 | MP0005671_abnormal_response_to | 1.39766122 |
| 58 | MP0003075_altered_response_to | 1.38774392 |
| 59 | MP0008789_abnormal_olfactory_epithelium | 1.37033630 |
| 60 | MP0002148_abnormal_hypersensitivity_rea | 1.36717190 |
| 61 | MP0009046_muscle_twitch | 1.36212805 |
| 62 | MP0002067_abnormal_sensory_capabilities | 1.35830495 |
| 63 | MP0001502_abnormal_circadian_rhythm | 1.34749974 |
| 64 | MP0001501_abnormal_sleep_pattern | 1.33575307 |
| 65 | MP0006082_CNS_inflammation | 1.33389561 |
| 66 | MP0003941_abnormal_skin_development | 1.31993162 |
| 67 | MP0005257_abnormal_intraocular_pressure | 1.29647022 |
| 68 | MP0002090_abnormal_vision | 1.29006958 |
| 69 | MP0009780_abnormal_chondrocyte_physiolo | 1.28053405 |
| 70 | MP0001346_abnormal_lacrimal_gland | 1.27254850 |
| 71 | MP0000013_abnormal_adipose_tissue | 1.25972472 |
| 72 | MP0004742_abnormal_vestibular_system | 1.24022921 |
| 73 | MP0005499_abnormal_olfactory_system | 1.22847061 |
| 74 | MP0005394_taste/olfaction_phenotype | 1.22847061 |
| 75 | MP0003633_abnormal_nervous_system | 1.22027668 |
| 76 | MP0001873_stomach_inflammation | 1.21595309 |
| 77 | MP0002909_abnormal_adrenal_gland | 1.20980103 |
| 78 | MP0001853_heart_inflammation | 1.20421447 |
| 79 | MP0005423_abnormal_somatic_nervous | 1.18175323 |
| 80 | MP0002938_white_spotting | 1.17825270 |
| 81 | MP0005379_endocrine/exocrine_gland_phen | 1.17523893 |
| 82 | MP0000538_abnormal_urinary_bladder | 1.17493559 |
| 83 | MP0000015_abnormal_ear_pigmentation | 1.17255651 |
| 84 | MP0000647_abnormal_sebaceous_gland | 1.16620792 |
| 85 | MP0001986_abnormal_taste_sensitivity | 1.15453592 |
| 86 | MP0000372_irregular_coat_pigmentation | 1.14591427 |
| 87 | MP0004043_abnormal_pH_regulation | 1.14288270 |
| 88 | MP0005174_abnormal_tail_pigmentation | 1.13509787 |
| 89 | MP0002697_abnormal_eye_size | 1.12785565 |
| 90 | MP0002184_abnormal_innervation | 1.11920793 |
| 91 | MP0003879_abnormal_hair_cell | 1.11110735 |
| 92 | MP0000534_abnormal_ureter_morphology | 1.10930019 |
| 93 | MP0003121_genomic_imprinting | 1.10132040 |
| 94 | MP0002234_abnormal_pharynx_morphology | 1.10017046 |
| 95 | MP0003300_gastrointestinal_ulcer | 1.08850624 |
| 96 | MP0002876_abnormal_thyroid_physiology | 1.08726045 |
| 97 | MP0002751_abnormal_autonomic_nervous | 1.07440719 |
| 98 | MP0000427_abnormal_hair_cycle | 1.07374594 |
| 99 | MP0002653_abnormal_ependyma_morphology | 1.07324410 |
| 100 | MP0000631_abnormal_neuroendocrine_gland | 1.05816471 |
| 101 | MP0004883_abnormal_blood_vessel | 1.05588509 |
| 102 | MP0002752_abnormal_somatic_nervous | 1.05119134 |
| 103 | MP0005000_abnormal_immune_tolerance | 1.04807794 |
| 104 | MP0001790_abnormal_immune_system | 1.04230645 |
| 105 | MP0005387_immune_system_phenotype | 1.04230645 |
| 106 | MP0002229_neurodegeneration | 1.04115413 |
| 107 | MP0001963_abnormal_hearing_physiology | 1.02965916 |
| 108 | MP0008260_abnormal_autophagy | 1.02631102 |
| 109 | MP0003195_calcinosis | 1.02366534 |
| 110 | MP0006292_abnormal_olfactory_placode | 1.02224865 |
| 111 | MP0005647_abnormal_sex_gland | 1.01205171 |
| 112 | MP0004145_abnormal_muscle_electrophysio | 1.01167593 |
| 113 | MP0005195_abnormal_posterior_eye | 0.98981298 |
| 114 | MP0000685_abnormal_immune_system | 0.98528401 |
| 115 | MP0002095_abnormal_skin_pigmentation | 0.96905384 |
| 116 | MP0005391_vision/eye_phenotype | 0.96319963 |
| 117 | MP0000026_abnormal_inner_ear | 0.95995451 |
| 118 | MP0002272_abnormal_nervous_system | 0.95864839 |
| 119 | MP0001299_abnormal_eye_distance/ | 0.94823599 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.94466099 |
| 121 | MP0003137_abnormal_impulse_conducting | 0.94232854 |
| 122 | MP0001188_hyperpigmentation | 0.93860641 |
| 123 | MP0001485_abnormal_pinna_reflex | 0.91490639 |
| 124 | MP0002233_abnormal_nose_morphology | 0.91472178 |
| 125 | MP0002928_abnormal_bile_duct | 0.90822169 |
| 126 | MP0003303_peritoneal_inflammation | 0.90787107 |
| 127 | MP0000383_abnormal_hair_follicle | 0.90362264 |
| 128 | MP0008877_abnormal_DNA_methylation | 0.90344445 |
| 129 | MP0002882_abnormal_neuron_morphology | 0.90266314 |
| 130 | MP0000955_abnormal_spinal_cord | 0.89910282 |
| 131 | MP0009785_altered_susceptibility_to | 0.89752356 |
| 132 | MP0002066_abnormal_motor_capabilities/c | 0.89557177 |
| 133 | MP0004811_abnormal_neuron_physiology | 0.89286807 |
| 134 | MP0009764_decreased_sensitivity_to | 0.87790817 |
| 135 | MP0003890_abnormal_embryonic-extraembry | 0.86913821 |
| 136 | MP0008569_lethality_at_weaning | 0.84753017 |
| 137 | MP0004133_heterotaxia | 0.84704751 |
| 138 | MP0000049_abnormal_middle_ear | 0.84510149 |
| 139 | MP0000516_abnormal_urinary_system | 0.84492407 |
| 140 | MP0005367_renal/urinary_system_phenotyp | 0.84492407 |
| 141 | MP0002069_abnormal_eating/drinking_beha | 0.84028055 |
| 142 | MP0002452_abnormal_antigen_presenting | 0.83720817 |
| 143 | MP0003631_nervous_system_phenotype | 0.83151504 |
| 144 | MP0003329_amyloid_beta_deposits | 0.81698638 |
| 145 | MP0005197_abnormal_uvea_morphology | 0.81345319 |
| 146 | MP0002723_abnormal_immune_serum | 0.78383019 |
| 147 | MP0003436_decreased_susceptibility_to | 0.76788981 |
| 148 | MP0002152_abnormal_brain_morphology | 0.76447989 |
| 149 | MP0002163_abnormal_gland_morphology | 0.75003336 |
| 150 | MP0005464_abnormal_platelet_physiology | 0.74621006 |
| 151 | MP0005025_abnormal_response_to | 0.74462118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nuclear cataract (HP:0100018) | 5.92783278 |
| 2 | Zonular cataract (HP:0010920) | 5.17199484 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 3.61070196 |
| 4 | Clumsiness (HP:0002312) | 3.56418869 |
| 5 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.36994791 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 3.30866173 |
| 7 | Dysostosis multiplex (HP:0000943) | 3.15436258 |
| 8 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.14501250 |
| 9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.14501250 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 3.14501250 |
| 11 | Pancreatic fibrosis (HP:0100732) | 3.11297537 |
| 12 | Eczematoid dermatitis (HP:0000976) | 3.08087994 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 3.05639942 |
| 14 | Focal motor seizures (HP:0011153) | 3.04513706 |
| 15 | Hepatoblastoma (HP:0002884) | 3.03431994 |
| 16 | Recurrent abscess formation (HP:0002722) | 2.99003322 |
| 17 | Pancreatic cysts (HP:0001737) | 2.97900570 |
| 18 | Genital tract atresia (HP:0001827) | 2.91256725 |
| 19 | Broad-based gait (HP:0002136) | 2.90303202 |
| 20 | Type II lissencephaly (HP:0007260) | 2.88403143 |
| 21 | Epileptic encephalopathy (HP:0200134) | 2.85068828 |
| 22 | Hyperventilation (HP:0002883) | 2.78982899 |
| 23 | Molar tooth sign on MRI (HP:0002419) | 2.78467250 |
| 24 | Abnormality of midbrain morphology (HP:0002418) | 2.78467250 |
| 25 | Vaginal atresia (HP:0000148) | 2.78233567 |
| 26 | Mutism (HP:0002300) | 2.76577678 |
| 27 | Arterial tortuosity (HP:0005116) | 2.74298397 |
| 28 | Gaze-evoked nystagmus (HP:0000640) | 2.67448825 |
| 29 | Abnormality of the labia minora (HP:0012880) | 2.61676416 |
| 30 | Oligodactyly (hands) (HP:0001180) | 2.59812908 |
| 31 | Atonic seizures (HP:0010819) | 2.56734698 |
| 32 | Nephronophthisis (HP:0000090) | 2.53469056 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 2.49820326 |
| 34 | Vacuolated lymphocytes (HP:0001922) | 2.47902276 |
| 35 | Large eyes (HP:0001090) | 2.46860762 |
| 36 | Action tremor (HP:0002345) | 2.45428638 |
| 37 | Limb dystonia (HP:0002451) | 2.44743440 |
| 38 | Retinal atrophy (HP:0001105) | 2.40978651 |
| 39 | Lissencephaly (HP:0001339) | 2.40666063 |
| 40 | Supranuclear gaze palsy (HP:0000605) | 2.40517537 |
| 41 | Hemiplegia (HP:0002301) | 2.39538222 |
| 42 | Abnormality of the renal medulla (HP:0100957) | 2.39517128 |
| 43 | Pulmonary infiltrates (HP:0002113) | 2.38591531 |
| 44 | Progressive inability to walk (HP:0002505) | 2.36716057 |
| 45 | Epidermoid cyst (HP:0200040) | 2.35622067 |
| 46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.34917513 |
| 47 | Progressive cerebellar ataxia (HP:0002073) | 2.34361897 |
| 48 | Cerebellar dysplasia (HP:0007033) | 2.33613073 |
| 49 | Megalencephaly (HP:0001355) | 2.33306244 |
| 50 | Febrile seizures (HP:0002373) | 2.33280299 |
| 51 | Poor coordination (HP:0002370) | 2.32817049 |
| 52 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.31232319 |
| 53 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.30416948 |
| 54 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.30416948 |
| 55 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.30416948 |
| 56 | Progressive sensorineural hearing impairment (HP:0000408) | 2.30164932 |
| 57 | Mucopolysacchariduria (HP:0008155) | 2.29539644 |
| 58 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.29539644 |
| 59 | Abnormality of the renal cortex (HP:0011035) | 2.29025409 |
| 60 | Neurofibrillary tangles (HP:0002185) | 2.28816128 |
| 61 | Chronic hepatic failure (HP:0100626) | 2.27980375 |
| 62 | Congenital stationary night blindness (HP:0007642) | 2.27112817 |
| 63 | Dialeptic seizures (HP:0011146) | 2.26308992 |
| 64 | Postaxial hand polydactyly (HP:0001162) | 2.25489745 |
| 65 | Astrocytoma (HP:0009592) | 2.25479825 |
| 66 | Abnormality of the astrocytes (HP:0100707) | 2.25479825 |
| 67 | Pachygyria (HP:0001302) | 2.24656206 |
| 68 | Abnormality of binocular vision (HP:0011514) | 2.18608705 |
| 69 | Diplopia (HP:0000651) | 2.18608705 |
| 70 | Vascular tortuosity (HP:0004948) | 2.18405050 |
| 71 | Inappropriate behavior (HP:0000719) | 2.17384167 |
| 72 | Renal cortical cysts (HP:0000803) | 2.15822740 |
| 73 | Congenital primary aphakia (HP:0007707) | 2.12807112 |
| 74 | Apathy (HP:0000741) | 2.11673270 |
| 75 | Intestinal atresia (HP:0011100) | 2.09979322 |
| 76 | Abnormal hair whorl (HP:0010721) | 2.09159333 |
| 77 | Protruding tongue (HP:0010808) | 2.07454214 |
| 78 | Retinal dysplasia (HP:0007973) | 2.07212173 |
| 79 | Keratoconus (HP:0000563) | 2.05903853 |
| 80 | Increased corneal curvature (HP:0100692) | 2.05903853 |
| 81 | Broad foot (HP:0001769) | 2.05832713 |
| 82 | Morphological abnormality of the inner ear (HP:0011390) | 2.04222193 |
| 83 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.02579309 |
| 84 | Colon cancer (HP:0003003) | 2.02505947 |
| 85 | Neuronal loss in central nervous system (HP:0002529) | 2.02405250 |
| 86 | Corneal dystrophy (HP:0001131) | 2.01903601 |
| 87 | Large for gestational age (HP:0001520) | 2.01017879 |
| 88 | Chorioretinal atrophy (HP:0000533) | 2.00963458 |
| 89 | Absence seizures (HP:0002121) | 2.00658356 |
| 90 | Stereotypic behavior (HP:0000733) | 2.00476054 |
| 91 | Glioma (HP:0009733) | 1.99787927 |
| 92 | Gait imbalance (HP:0002141) | 1.98675836 |
| 93 | Absent speech (HP:0001344) | 1.98381428 |
| 94 | Split foot (HP:0001839) | 1.98322768 |
| 95 | Short foot (HP:0001773) | 1.97851214 |
| 96 | Occipital encephalocele (HP:0002085) | 1.97802520 |
| 97 | Polyphagia (HP:0002591) | 1.97783366 |
| 98 | Heterochromia iridis (HP:0001100) | 1.97277895 |
| 99 | Short tibia (HP:0005736) | 1.97135401 |
| 100 | Generalized myoclonic seizures (HP:0002123) | 1.96993167 |
| 101 | Optic nerve hypoplasia (HP:0000609) | 1.96647446 |
| 102 | Diminished motivation (HP:0000745) | 1.96083344 |
| 103 | Drooling (HP:0002307) | 1.95298391 |
| 104 | Excessive salivation (HP:0003781) | 1.95298391 |
| 105 | Neoplasm of the adrenal cortex (HP:0100641) | 1.93060857 |
| 106 | Urethral obstruction (HP:0000796) | 1.92469614 |
| 107 | Focal seizures (HP:0007359) | 1.92402622 |
| 108 | Attenuation of retinal blood vessels (HP:0007843) | 1.90995095 |
| 109 | Left ventricular hypertrophy (HP:0001712) | 1.90127320 |
| 110 | Oligodactyly (HP:0012165) | 1.89883325 |
| 111 | Epileptiform EEG discharges (HP:0011182) | 1.89261525 |
| 112 | Postaxial foot polydactyly (HP:0001830) | 1.88455176 |
| 113 | EEG with generalized epileptiform discharges (HP:0011198) | 1.87937806 |
| 114 | Fair hair (HP:0002286) | 1.87645617 |
| 115 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.87459813 |
| 116 | Agnosia (HP:0010524) | 1.87429776 |
| 117 | Abolished electroretinogram (ERG) (HP:0000550) | 1.87311809 |
| 118 | Cystic liver disease (HP:0006706) | 1.87286421 |
| 119 | Adactyly (HP:0009776) | 1.87199787 |
| 120 | Hemiparesis (HP:0001269) | 1.86320952 |
| 121 | Congenital sensorineural hearing impairment (HP:0008527) | 1.85762834 |
| 122 | Renal hypoplasia (HP:0000089) | 1.85369879 |
| 123 | Amblyopia (HP:0000646) | 1.85176609 |
| 124 | Abnormality of macular pigmentation (HP:0008002) | 1.84534402 |
| 125 | Ankle clonus (HP:0011448) | 1.83925881 |
| 126 | Agitation (HP:0000713) | 1.82603700 |
| 127 | Disinhibition (HP:0000734) | 1.82451124 |
| 128 | Hypoplastic iliac wings (HP:0002866) | 1.81320476 |
| 129 | Hypsarrhythmia (HP:0002521) | 1.81290814 |
| 130 | Blue irides (HP:0000635) | 1.80324491 |
| 131 | Narrow forehead (HP:0000341) | 1.80169320 |
| 132 | Hypothermia (HP:0002045) | 1.79927785 |
| 133 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.79849796 |
| 134 | Aplasia of the phalanges of the hand (HP:0009802) | 1.79849796 |
| 135 | Aplasia involving bones of the extremities (HP:0009825) | 1.79849796 |
| 136 | Progressive macrocephaly (HP:0004481) | 1.79683526 |
| 137 | Abnormality of macrophages (HP:0004311) | 1.78967031 |
| 138 | Absent frontal sinuses (HP:0002688) | 1.77479712 |
| 139 | Specific learning disability (HP:0001328) | 1.77289048 |
| 140 | Myokymia (HP:0002411) | 1.77025790 |
| 141 | Thyroid carcinoma (HP:0002890) | 1.76835851 |
| 142 | Progressive hearing impairment (HP:0001730) | 1.76583082 |
| 143 | Papillary thyroid carcinoma (HP:0002895) | 1.74521350 |
| 144 | Gingivitis (HP:0000230) | 1.74230046 |
| 145 | Bile duct proliferation (HP:0001408) | 1.73978657 |
| 146 | Abnormal biliary tract physiology (HP:0012439) | 1.73978657 |
| 147 | Hematochezia (HP:0002573) | 1.73464648 |
| 148 | Inability to walk (HP:0002540) | 1.72838882 |
| 149 | Basal ganglia calcification (HP:0002135) | 1.72703431 |
| 150 | Retrobulbar optic neuritis (HP:0100654) | 1.72083951 |
| 151 | Optic neuritis (HP:0100653) | 1.72083951 |
| 152 | Dysdiadochokinesis (HP:0002075) | 1.70978922 |
| 153 | Akinesia (HP:0002304) | 1.70890028 |
| 154 | Tetraparesis (HP:0002273) | 1.70597402 |
| 155 | Abnormal drinking behavior (HP:0030082) | 1.70286626 |
| 156 | Polydipsia (HP:0001959) | 1.70286626 |
| 157 | Stomach cancer (HP:0012126) | 1.69407084 |
| 158 | Eosinophilia (HP:0001880) | 1.68040508 |
| 159 | Tubulointerstitial nephritis (HP:0001970) | 1.67747168 |
| 160 | Medial flaring of the eyebrow (HP:0010747) | 1.65591487 |
| 161 | Widely spaced teeth (HP:0000687) | 1.65363061 |
| 162 | Abnormal eating behavior (HP:0100738) | 1.64033278 |
| 163 | Nephrogenic diabetes insipidus (HP:0009806) | 1.63688245 |
| 164 | Progressive visual loss (HP:0000529) | 1.63432324 |
| 165 | Glomerulonephritis (HP:0000099) | 1.62553584 |
| 166 | Postural instability (HP:0002172) | 1.62035572 |
| 167 | Septo-optic dysplasia (HP:0100842) | 1.61901404 |
| 168 | Stomatitis (HP:0010280) | 1.61453977 |
| 169 | Broad ribs (HP:0000885) | 1.59094554 |
| 170 | Leiomyosarcoma (HP:0100243) | 1.58699103 |
| 171 | Uterine leiomyosarcoma (HP:0002891) | 1.58699103 |
| 172 | True hermaphroditism (HP:0010459) | 1.57976542 |
| 173 | Generalized tonic-clonic seizures (HP:0002069) | 1.57693446 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.98829962 |
| 2 | MAP4K2 | 4.07394339 |
| 3 | WNK3 | 3.05176393 |
| 4 | NTRK2 | 2.61281150 |
| 5 | MAPK13 | 2.53382783 |
| 6 | NTRK3 | 2.52764593 |
| 7 | MARK1 | 2.36865554 |
| 8 | RIPK4 | 2.30912785 |
| 9 | BCR | 2.27896218 |
| 10 | PINK1 | 2.21997867 |
| 11 | CSNK1G2 | 2.13737896 |
| 12 | CSNK1G3 | 2.09695801 |
| 13 | CSNK1G1 | 2.06944510 |
| 14 | CAMK1G | 2.05916264 |
| 15 | CAMK1D | 2.03803622 |
| 16 | TAOK3 | 1.99561464 |
| 17 | CSNK1A1L | 1.90986560 |
| 18 | PAK3 | 1.89833169 |
| 19 | MAP2K7 | 1.89041620 |
| 20 | BMPR1B | 1.83493393 |
| 21 | PHKG2 | 1.74451994 |
| 22 | PHKG1 | 1.74451994 |
| 23 | SGK2 | 1.60219289 |
| 24 | MAP3K12 | 1.56381892 |
| 25 | MAPK15 | 1.56145949 |
| 26 | TRIM28 | 1.54369385 |
| 27 | MAP3K4 | 1.53716799 |
| 28 | SIK3 | 1.47317271 |
| 29 | GRK7 | 1.43118970 |
| 30 | DMPK | 1.37533292 |
| 31 | NUAK1 | 1.37407822 |
| 32 | KIT | 1.31286263 |
| 33 | TBK1 | 1.30889271 |
| 34 | FES | 1.30755362 |
| 35 | YES1 | 1.28699742 |
| 36 | INSRR | 1.28371968 |
| 37 | STK38L | 1.26517359 |
| 38 | IRAK1 | 1.26145338 |
| 39 | IRAK2 | 1.24118077 |
| 40 | PLK2 | 1.23407865 |
| 41 | BMPR2 | 1.23154246 |
| 42 | SIK2 | 1.22305554 |
| 43 | TGFBR2 | 1.17409699 |
| 44 | CAMKK2 | 1.17266462 |
| 45 | TYK2 | 1.15175480 |
| 46 | IRAK4 | 1.14776900 |
| 47 | SGK3 | 1.12975734 |
| 48 | TNIK | 1.10788521 |
| 49 | JAK3 | 1.10182805 |
| 50 | MAP3K14 | 1.09164389 |
| 51 | CCNB1 | 1.07734533 |
| 52 | STK39 | 1.07654435 |
| 53 | EPHA4 | 1.07461667 |
| 54 | CSF1R | 1.07157109 |
| 55 | FGR | 1.06841694 |
| 56 | FRK | 1.06172982 |
| 57 | FER | 1.05452005 |
| 58 | GRK1 | 1.05079027 |
| 59 | PDGFRA | 1.02080379 |
| 60 | SGK223 | 1.02018333 |
| 61 | SGK494 | 1.02018333 |
| 62 | JAK1 | 0.99106922 |
| 63 | ADRBK2 | 0.98999860 |
| 64 | MST4 | 0.98753689 |
| 65 | MAP3K9 | 0.97641919 |
| 66 | PNCK | 0.96005046 |
| 67 | FGFR2 | 0.95768961 |
| 68 | RET | 0.94996582 |
| 69 | CDK5 | 0.94361781 |
| 70 | PRKCE | 0.91385348 |
| 71 | LMTK2 | 0.90402776 |
| 72 | MINK1 | 0.89394380 |
| 73 | PRPF4B | 0.89223066 |
| 74 | EPHA3 | 0.89116080 |
| 75 | OBSCN | 0.88310088 |
| 76 | IRAK3 | 0.88059612 |
| 77 | MAP2K4 | 0.87096438 |
| 78 | MATK | 0.86838968 |
| 79 | ACVR1B | 0.86667902 |
| 80 | RPS6KA2 | 0.86460803 |
| 81 | EIF2AK2 | 0.84808194 |
| 82 | SGK1 | 0.83612557 |
| 83 | DYRK2 | 0.81286204 |
| 84 | PKN1 | 0.80811378 |
| 85 | CAMKK1 | 0.79949403 |
| 86 | KSR1 | 0.78141236 |
| 87 | PAK6 | 0.78024518 |
| 88 | UHMK1 | 0.71590890 |
| 89 | BMX | 0.69410725 |
| 90 | AKT3 | 0.69386673 |
| 91 | CHUK | 0.68679510 |
| 92 | CDK3 | 0.68425286 |
| 93 | SIK1 | 0.68264802 |
| 94 | ERBB4 | 0.66994635 |
| 95 | MUSK | 0.65826664 |
| 96 | PRKD3 | 0.65575080 |
| 97 | NTRK1 | 0.64167483 |
| 98 | CAMK2B | 0.63887007 |
| 99 | BCKDK | 0.63334607 |
| 100 | TSSK6 | 0.63261359 |
| 101 | BLK | 0.63183959 |
| 102 | DAPK2 | 0.62427811 |
| 103 | PDK2 | 0.61085396 |
| 104 | MKNK2 | 0.60286253 |
| 105 | STK24 | 0.59408686 |
| 106 | CSNK1D | 0.58776916 |
| 107 | ADRBK1 | 0.57946350 |
| 108 | DAPK1 | 0.56070140 |
| 109 | CAMK2D | 0.54677095 |
| 110 | DYRK1A | 0.54300383 |
| 111 | BRSK2 | 0.54122630 |
| 112 | TIE1 | 0.54049024 |
| 113 | PIK3CA | 0.53320288 |
| 114 | VRK1 | 0.52857113 |
| 115 | EIF2AK3 | 0.52303999 |
| 116 | PDGFRB | 0.51493032 |
| 117 | ROCK1 | 0.50809354 |
| 118 | JAK2 | 0.50569412 |
| 119 | PRKAA1 | 0.49756092 |
| 120 | CSNK1A1 | 0.49469905 |
| 121 | CAMK4 | 0.48424425 |
| 122 | PRKG1 | 0.47789240 |
| 123 | ERBB3 | 0.47293111 |
| 124 | PRKACA | 0.47042970 |
| 125 | PRKCG | 0.46774477 |
| 126 | LIMK1 | 0.45512348 |
| 127 | CAMK2A | 0.44668907 |
| 128 | NEK6 | 0.43629931 |
| 129 | WEE1 | 0.43392374 |
| 130 | LYN | 0.43263465 |
| 131 | WNK4 | 0.42738008 |
| 132 | PTK2B | 0.42735727 |
| 133 | HCK | 0.41748075 |
| 134 | PRKCZ | 0.41678830 |
| 135 | IKBKB | 0.40925745 |
| 136 | PRKACB | 0.40260953 |
| 137 | OXSR1 | 0.39084449 |
| 138 | IGF1R | 0.38987527 |
| 139 | SYK | 0.38689746 |
| 140 | FGFR3 | 0.36666005 |
| 141 | MKNK1 | 0.36544974 |
| 142 | IKBKE | 0.36180600 |
| 143 | STK3 | 0.36130224 |
| 144 | PRKCB | 0.35346723 |
| 145 | CAMK2G | 0.34187409 |
| 146 | CAMK1 | 0.34058015 |
| 147 | TGFBR1 | 0.33629108 |
| 148 | CSNK1E | 0.32990785 |
| 149 | RAF1 | 0.32255910 |
| 150 | ROCK2 | 0.31072813 |
| 151 | STK38 | 0.30796104 |
| 152 | ERBB2 | 0.30115325 |
| 153 | PRKDC | 0.29978565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.37143642 |
| 2 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.80488810 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.40491055 |
| 4 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.33342563 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.07942875 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.01018051 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.99427061 |
| 8 | Phototransduction_Homo sapiens_hsa04744 | 1.89376311 |
| 9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.86824675 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.83412051 |
| 11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.83130558 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.82594623 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.81464578 |
| 14 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.80295173 |
| 15 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.76975460 |
| 16 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.74884950 |
| 17 | Protein export_Homo sapiens_hsa03060 | 1.70307155 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.69173029 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.68786169 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.60585250 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.55510749 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.52421965 |
| 23 | Morphine addiction_Homo sapiens_hsa05032 | 1.52285150 |
| 24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.51049285 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.48636152 |
| 26 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.46878016 |
| 27 | GABAergic synapse_Homo sapiens_hsa04727 | 1.44973671 |
| 28 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.43962852 |
| 29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.43248530 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.40060809 |
| 31 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.38556062 |
| 32 | Phagosome_Homo sapiens_hsa04145 | 1.38335401 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.37746289 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.34674753 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.33785879 |
| 36 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.31959907 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26960846 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.26355752 |
| 39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.25168081 |
| 40 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.24612327 |
| 41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.21172792 |
| 42 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.19417265 |
| 43 | Olfactory transduction_Homo sapiens_hsa04740 | 1.18408372 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.16138416 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 1.15778947 |
| 46 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.13161543 |
| 47 | Legionellosis_Homo sapiens_hsa05134 | 1.12616944 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 1.12574059 |
| 49 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12003061 |
| 50 | Circadian entrainment_Homo sapiens_hsa04713 | 1.09298393 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 1.07360649 |
| 52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.07173891 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.06406712 |
| 54 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.03157814 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.02959066 |
| 56 | Cocaine addiction_Homo sapiens_hsa05030 | 1.02587333 |
| 57 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02535559 |
| 58 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.01862430 |
| 59 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.00286148 |
| 60 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.99397221 |
| 61 | Malaria_Homo sapiens_hsa05144 | 0.99270138 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.96615396 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.96430890 |
| 64 | Glioma_Homo sapiens_hsa05214 | 0.95996742 |
| 65 | Insulin secretion_Homo sapiens_hsa04911 | 0.95328651 |
| 66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.94563412 |
| 67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94367508 |
| 68 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.93250021 |
| 69 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.93151390 |
| 70 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.92960531 |
| 71 | Measles_Homo sapiens_hsa05162 | 0.91317975 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.90741386 |
| 73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89712226 |
| 74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.89663878 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.89089132 |
| 76 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.88599277 |
| 77 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.87364147 |
| 78 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86726282 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.86326334 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85737766 |
| 81 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.85139622 |
| 82 | Long-term potentiation_Homo sapiens_hsa04720 | 0.84136468 |
| 83 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.83376802 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.82864337 |
| 85 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.81893659 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79836357 |
| 87 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.79438162 |
| 88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.78632474 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.78565045 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76663625 |
| 91 | Taste transduction_Homo sapiens_hsa04742 | 0.76541367 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76254664 |
| 93 | Renin secretion_Homo sapiens_hsa04924 | 0.75917321 |
| 94 | Salivary secretion_Homo sapiens_hsa04970 | 0.75683346 |
| 95 | Basal transcription factors_Homo sapiens_hsa03022 | 0.75388623 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75105706 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.75004126 |
| 98 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74973692 |
| 99 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.74520279 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74106498 |
| 101 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.73668807 |
| 102 | Long-term depression_Homo sapiens_hsa04730 | 0.72669840 |
| 103 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.72577907 |
| 104 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.72535236 |
| 105 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.71612796 |
| 106 | Axon guidance_Homo sapiens_hsa04360 | 0.70786034 |
| 107 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70780468 |
| 108 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.70739262 |
| 109 | Circadian rhythm_Homo sapiens_hsa04710 | 0.69868788 |
| 110 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.69800139 |
| 111 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.69447655 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67813970 |
| 113 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.67266176 |
| 114 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.67135268 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66877143 |
| 116 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.66640384 |
| 117 | Gap junction_Homo sapiens_hsa04540 | 0.65991937 |
| 118 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.65664338 |
| 119 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65632130 |
| 120 | Asthma_Homo sapiens_hsa05310 | 0.65539976 |
| 121 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65327021 |
| 122 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.64706032 |
| 123 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64150209 |
| 124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63935570 |
| 125 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.63517989 |
| 126 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62860951 |
| 127 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.62765797 |
| 128 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.62252276 |
| 129 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.61137162 |
| 130 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.60693160 |
| 131 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.60409077 |
| 132 | Histidine metabolism_Homo sapiens_hsa00340 | 0.59941706 |
| 133 | Amoebiasis_Homo sapiens_hsa05146 | 0.59776364 |
| 134 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59623473 |
| 135 | Hepatitis B_Homo sapiens_hsa05161 | 0.58929345 |
| 136 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.58650668 |
| 137 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58413550 |
| 138 | Endocytosis_Homo sapiens_hsa04144 | 0.57568237 |
| 139 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.57233297 |
| 140 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.57182888 |
| 141 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.55824012 |
| 142 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.55687027 |
| 143 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55308478 |
| 144 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.55090970 |
| 145 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54503650 |
| 146 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54407731 |
| 147 | Retinol metabolism_Homo sapiens_hsa00830 | 0.53855871 |
| 148 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53647694 |
| 149 | Hepatitis C_Homo sapiens_hsa05160 | 0.52781782 |
| 150 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52525957 |
| 151 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.52284297 |
| 152 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.51967090 |
| 153 | Shigellosis_Homo sapiens_hsa05131 | 0.51769556 |
| 154 | Bile secretion_Homo sapiens_hsa04976 | 0.51704157 |
| 155 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51685623 |
| 156 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.51669572 |
| 157 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51219075 |
| 158 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51067065 |
| 159 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.49844312 |
| 160 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.48545808 |
| 161 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43140698 |
| 162 | Tight junction_Homo sapiens_hsa04530 | 0.40792841 |
| 163 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39143332 |
| 164 | Parkinsons disease_Homo sapiens_hsa05012 | 0.36886779 |

